Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Qalsody
Qalsody
5 Reasons Biogen’s Shares Have Dropped 36% in 2024
BioSpace
Thu, 11/14/24 - 11:19 am
Biogen
Leqembi
Qalsody
Skyclary
Zurzuvae
Spinraza
European Commission grants marketing approval to Biogen's ALS drug
Reuters
Thu, 05/30/24 - 11:05 pm
Biogen
Europe
Ionis Pharmaceuticals
ALS
Qalsody
EU medicines regulator backs Biogen's ALS drug
Reuters
Fri, 02/23/24 - 10:28 am
Biogen
Europe
ALS
Qalsody
6 Drugs Approved Despite Failed Trials or Minimal Data
BioSpace
Mon, 10/9/23 - 11:10 am
Ipsen
Sohonos
Sarepta Therapeutics
Elevidys
Biogen
Qalsody
Eisai
Aduhelm
Jazz Pharma
PharmaMar
Zepzelca
Acadia Pharma
Nuplazid
Quanterix sees a bright future for blood biomarkers
EP Vantage
Fri, 06/2/23 - 10:08 am
Biogen
Quanterix
diagnostics
Qalsody
ALS
biomarkers
Will Biogen’s Qalsody Be a Catalyst for Gene-Specific ALS Research?
BioSpace
Thu, 04/27/23 - 11:51 am
Biogen
Qalsody
tofersen
ALS
drug development
R&D